drugset / Trial / NCT03844906
A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects
RandomizedCrossoverQuadruple-blindBasic science
Summary
This study is a Phase 1, randomized, double-blind, placebo-controlled study of multiple doses of SAGE-718 using ketamine challenge to evaluate the electrophysiology, safety, tolerability, and pharmacokinetics in healthy subjects.
Timeline
- Start
- 2018-12-27
- Primary completion
- 2019-03-18
- Completion
- 2019-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalzanemdor | Small molecule | — | — |
| Background | Ketamine | Small molecule | — | — |
Indications
No indication recorded.